Therefore, it may be the case that previous conflicting evidence on the directionality of the effect of RTEL1 expression on glioma risk may be confounded due to non-canonical transcript variants; though, further studies would be required to ascertain if this is the case. This evidence concerns the gene RTEL1 and glioma.